Onset of Action of Azelastine 0.15% Versus Olopatadine/Mometasone for Allergen-Induced Rhinitis: An EEU Crossover Study.

Bousquet J, Klimek L, Kuhl HC, Nguyen DT, Kumar R, Berger WE

Open source

DOI
10.1002/clt2.70213
Published
2026 Nov
Container
Clinical and translational allergy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/clt2.70213,
  title = {Onset of Action of Azelastine 0.15\% Versus Olopatadine/Mometasone for Allergen-Induced Rhinitis: An EEU Crossover Study.},
  author = {Bousquet J and Klimek L and Kuhl HC and Nguyen DT and Kumar R and Berger WE},
  year = {2026},
  journal = {Clinical and translational allergy},
  doi = {10.1002/clt2.70213},
  url = {https://doi.org/10.1002/clt2.70213}
}

RIS

TY  - JOUR
TI  - Onset of Action of Azelastine 0.15% Versus Olopatadine/Mometasone for Allergen-Induced Rhinitis: An EEU Crossover Study.
AU  - Bousquet J
AU  - Klimek L
AU  - Kuhl HC
AU  - Nguyen DT
AU  - Kumar R
AU  - Berger WE
PY  - 2026
JO  - Clinical and translational allergy
DO  - 10.1002/clt2.70213
UR  - https://doi.org/10.1002/clt2.70213
ER  - 

APA

J, B., L, K., HC, K., DT, N., R, K., & WE, B. (2026). Onset of Action of Azelastine 0.15% Versus Olopatadine/Mometasone for Allergen-Induced Rhinitis: An EEU Crossover Study.. Clinical and translational allergy. https://doi.org/10.1002/clt2.70213

Source records